Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionLong-acting oxyntomodulin formulated with reversible-pegylation technology
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R) ; Glucagon receptor (GCGR)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist; Glucagon receptor agonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today